These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21986812)

  • 21. Lack of c-kit (CD117) expression in CD30+ lymphomas and lymphomatoid papulosis.
    Rassidakis GZ; Georgakis GV; Oyarzo M; Younes A; Medeiros LJ
    Mod Pathol; 2004 Aug; 17(8):946-53. PubMed ID: 15105813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.
    Toda T; Watanabe M; Kawato J; Kadin ME; Higashihara M; Kunisada T; Umezawa K; Horie R
    Br J Haematol; 2015 Sep; 170(6):837-46. PubMed ID: 26105086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signal transduction in anaplastic large cell lymphoma cells (ALCL) mediated by the tumor necrosis factor receptor CD30.
    Schneider C; Stöhr D; Merz H; Hübinger G
    Leuk Lymphoma; 2004 May; 45(5):1009-15. PubMed ID: 15291361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation.
    Hübinger G; Scheffrahn I; Müller E; Bai R; Duyster J; Morris SW; Schrezenmeier H; Bergmann L
    Exp Hematol; 1999 Dec; 27(12):1796-805. PubMed ID: 10641597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD30 Induces Heat Shock Protein 90 and Signal Integration in Classic Hodgkin Lymphoma Cells.
    Watanabe M; Nakano K; Kadin ME; Higashihara M; Watanabe T; Horie R
    Am J Pathol; 2017 Jan; 187(1):163-175. PubMed ID: 27870927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-level expression of BCL3 differentiates t(2;5)(p23;q35)-positive anaplastic large cell lymphoma from Hodgkin disease.
    Nishikori M; Maesako Y; Ueda C; Kurata M; Uchiyama T; Ohno H
    Blood; 2003 Apr; 101(7):2789-96. PubMed ID: 12456498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Galectin-1-mediated cell adhesion, invasion and cell death in human anaplastic large cell lymphoma: regulatory roles of cell surface glycans.
    Suzuki O; Abe M
    Int J Oncol; 2014 May; 44(5):1433-42. PubMed ID: 24589677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of the human anti-CD30 antibody 5F11 with cytostatic drugs enhances its antitumor activity against Hodgkin and anaplastic large cell lymphoma cell lines.
    Heuck F; Ellermann J; Borchmann P; Rothe A; Hansen H; Engert A; von Strandmann EP
    J Immunother; 2004; 27(5):347-53. PubMed ID: 15314543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High intratumoural galectin-1 expression predicts adverse outcome in ALK
    Holst JM; Ludvigsen M; Hamilton-Dutoit SJ; Bendix K; Plesner TL; Nørgaard P; Møller MB; Steiniche T; Rabinovich GA; d'Amore F; Pedersen MB
    Hematol Oncol; 2020 Feb; 38(1):59-66. PubMed ID: 31834627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Reed-Sternberg CD30 Receptor and Lymphocytes in Pathogenesis of Disease and Its Implication for Treatment.
    Rinaldi I
    Acta Med Indones; 2018 Apr; 50(2):93-95. PubMed ID: 29950526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NADPH oxidase NOX5 protects against apoptosis in ALK-positive anaplastic large-cell lymphoma cell lines.
    Carnesecchi S; Rougemont AL; Doroshow JH; Nagy M; Mouche S; Gumy-Pause F; Szanto I
    Free Radic Biol Med; 2015 Jul; 84():22-29. PubMed ID: 25797883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
    Buchan SL; Al-Shamkhani A
    PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Wei W; Song Z; Yang Y
    Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
    McQuaid DC; Katz SG; Xu ML
    Am J Clin Pathol; 2022 Aug; 158(2):173-176. PubMed ID: 35460405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment.
    Dumitru AV; Țăpoi DA; Halcu G; Munteanu O; Dumitrascu DI; Ceaușu MC; Gheorghișan-Gălățeanu AA
    Cells; 2023 Jul; 12(13):. PubMed ID: 37443818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crizotinib enhances anti-CD30-LDM induced antitumor efficacy in NPM-ALK positive anaplastic large cell lymphoma.
    Wang R; Li L; Duan A; Li Y; Liu X; Miao Q; Gong J; Zhen Y
    Cancer Lett; 2019 Apr; 448():84-93. PubMed ID: 30742941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
    Hübinger G; Müller E; Scheffrahn I; Schneider C; Hildt E; Singer BB; Sigg I; Graf J; Bergmann L
    Oncogene; 2001 Feb; 20(5):590-8. PubMed ID: 11313991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
    Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
    Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.